Investor
Digital diet and wellness company Noom led last quarter's funding with $540 million in Series F investments.
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.
Once combined, the company will operate as HeartFlow Group and trade on the NYSE under symbol HFLO.
The company currently runs a telehealth platform catering to men's health, fertility health, sexual wellness and skincare.
The Israeli company now has a total of $9 million in venture funding.
This brings the company's total raise to $140 million.
The company’s production studio has created over 2,000 original videos that span a variety of conditions and procedures.
During the COVID-19 pandemic rates of depression, anxiety and substance abuse increased.
The chronic disease management company also seeks to enter the Middle East and US markets.
The company is planning on using the new funds to expand its library and build more capabilities.